Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

Durvalumab improves prognosis of stage III non-small-cell lung cancer after definitive chemoradiotherapy (2018) Hecht M, Gaipl U, Fietkau R Journal article Lethal outcome after pelvic salvage radiotherapy in a patient with prostate cancer due to increased radiosensitivity : Case report and literature review (2018) Fahrig A, Koch T, Lenhart M, Rieckmann P, Fietkau R, Distel L, Schuster B Journal article Interaktionen von Strahlen- und Immuntherapie (2017) Rueckert M, Fietkau R, Frey B, Gaipl U Journal article, Review article Impact of radio(chemo)therapy on expression of immune checkpoint ligands PD-L1 and PD-L2 on murine and human melanoma cells (2017) Riegel D, Bäumler M, Spiljar M, Rückert M, Frey B, Fietkau R, Derer A, Gaipl U Conference contribution, Abstract of a poster Influence and mechanistic principles of radio(chemo) therapy on PD-L1 and EGF-R expression on melanoma and glioblastoma cells (2017) Baeumler M, Spiljar M, Frey B, Fietkau R, Gaipl U, Derer A Conference contribution, Abstract of lecture Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging (2017) Eze C, Roengvoraphoj O, Niyazi M, Hildebrandt G, Fietkau R, Belka C, Manapov F Journal article GLIO-CMV-01: Identification of immune biomarkers for CMV related encephalitis during standard brain radiotherapy (2017) Rühle PF, Goerig N, Korn K, Überla K, Wunderlich R, Fietkau R, Gaipl U, Frey B Conference contribution Immunological basis of abscopal antitumor responses induced with radio-immunotherapy (2017) Rueckert M, Frey B, Fietkau R, Gaipl U Conference contribution CBCT-based Detection and Analysis of the Positional Stability of implanted Gold Markers and Changes in the Shape of the Rectal Balloon during the Radiotherapy of the Prostate-Ca (2017) Kallis K, Brandt T, Strnad V, Lettmaier S, Fietkau R, Maier AK, Bert C Conference contribution Autologous whole tumor cell-based vaccines generated with high hydrostatic pressure bear immunogenic potential and act synergistically with radiotherapy to retard tumor growth (2017) Frey B, Seitz C, Weiss EM, Rueckert M, Schlücker E, Schaft N, Fietkau R, Gaipl U Conference contribution